Could a tiny dose of radiation tame this skin cancer?
NCT ID NCT07310745
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether a very low dose of radiation (4 Gy) can effectively control a rare, slow-growing type of skin lymphoma called primary indolent cutaneous B-cell lymphoma. Researchers will review records from 52 patients who received this low-dose treatment to see how long the cancer stays under control and what side effects occur. The goal is to find out if lower doses can work just as well as the standard higher doses, with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- low-dose radiotherapy (4 Gy)
- What this could lead to
- If successful, this could show that a much lower radiation dose is enough to control this rare skin lymphoma, reducing side effects while still being effective.
- What could go wrong
- This is a small, retrospective study (52 people), not a large controlled trial. The low dose may not work as well as standard higher doses, and the results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda USL IRCCS di Reggio Emilia - Sc Radioterapia
Reggio Emilia, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.